News

Explore Latest News .

Find all the latest news on Paul Peter Tak, as well as a comprehensive list of his past interviews and features. Paul Peter’s work in immunology and the pharmaceutical industry has led him to be featured in both business and medicine specific publications.

During his time at GlaxoSmithKline, Paul Peter gave a number of interviews and briefs, including one with the Biochemical Society in 2017. In this insightful interview, Paul Peter outlined what the GSK Immunology Network was and its impact on this important area of research.

In December 2020, Paul Peter Tak spoke with Eleanor Malone, from Scrip, about the work Candel Therapeutics was undertaking in the field of cancer immunotherapy and the companies ambitious future. Paul Peter has also had more broad discussions around his career and what inspires him, such as his interview with Stephanie Sutton for The Medicine Maker, in 2020.   

CAN-3110: Experimental treatment of glioblastoma.

Podcast People & Pioneers: Leadership and the paradigm shift in biotechnology

Leadership and the Paradigm Shift in Biotechnology: Insights from Paul Peter Tak, PhD, FMedSci, Professor, President, CEO & Board Director of Candel Therapeutics – People and Pioneers – The Podc…

The Future of Immunotherapy: An Interview with Dr. Tak

https://healthcarefuture.com/biotech/candel

The BioHub – The Avetix Podcast – Episode 5 – Paul Peter Tak

The BioHub – The Avetix Podcast – Episode 5 – Paul Peter Tak (youtube.com)

Viral Immunotherapy: Interview with Dr. Moira Gunn at BioTech Nation

Introduction Welcome to a riveting episode of this BioTech Nation podcast, where we delve into the cutting-edge realm of cancer treatments with Dr. Paul Peter Tack, the visionary CEO of Candel Th…

Dr. Paul Peter Tak was included in ‘the Medicine Maker Power List 2023’

The Medicine Maker Power List 2023 Celebrating 30 influential and inspirational leaders across small molecule, biopharmaceutical, and cell and gene therapy development and manufacture The Medi…
Paul Peter Tak

© Paul Peter Tak.
All rights reserved.